{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:50:23Z","timestamp":1791579023731,"version":"4.3.4"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-03047-3","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:15:12Z","timestamp":1791530112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroendocrine regulation of adipose partitioning in polyendocrine metabolic ovarian syndrome: the gut\u2013brain\u2013adipose axis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2134-2597","authenticated-orcid":false,"given":"Irmak","family":"Gunesli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-9381","authenticated-orcid":false,"given":"Seren","family":"Aksun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-7662","authenticated-orcid":false,"given":"Bulent Okan","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"3047_CR1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z et al (2016) Polycystic ovary syndrome. Nat Rev Dis Primers 2:16057. https:\/\/doi.org\/10.1038\/nrdp.2016.57","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3047_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106(1):6\u201315. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003","journal-title":"Fertil Steril"},{"issue":"12","key":"3047_CR3","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31(12):2841\u20132855. https:\/\/doi.org\/10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"key":"3047_CR4","doi-asserted-by":"publisher","unstructured":"Helvaci N, Yildiz BO (2024) Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol Published online November 28. https:\/\/doi.org\/10.1038\/s41574-024-01057-w","DOI":"10.1038\/s41574-024-01057-w"},{"issue":"4","key":"3047_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s40618-024-02512-1","volume":"48","author":"NG Lafci","year":"2024","unstructured":"Lafci NG, Yilmaz B, Yildiz BO (2024) PCOS - the many faces of a disorder in women and men. J Endocrinol Invest 48(4):785\u2013798. https:\/\/doi.org\/10.1007\/s40618-024-02512-1","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"3047_CR6","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H (2012) Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 27(10):3067\u20133073. https:\/\/doi.org\/10.1093\/humrep\/des232","journal-title":"Hum Reprod"},{"issue":"1","key":"3047_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1210\/clinem\/dgad356","volume":"109","author":"F Bril","year":"2023","unstructured":"Bril F, Ezeh U, Amiri M et al (2023) Adipose Tissue Dysfunction in Polycystic Ovary Syndrome. J Clin Endocrinol Metab 109(1):10\u201324. https:\/\/doi.org\/10.1210\/clinem\/dgad356","journal-title":"J Clin Endocrinol Metab"},{"key":"3047_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.steroids.2017.12.009","volume":"130","author":"B Echibur\u00fa","year":"2018","unstructured":"Echibur\u00fa B, P\u00e9rez-Bravo F, Galgani JE et al (2018) Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome. Steroids 130:15\u201321. https:\/\/doi.org\/10.1016\/j.steroids.2017.12.009","journal-title":"Steroids"},{"key":"3047_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jsbmb.2014.04.008","volume":"143","author":"MW O\u2019Reilly","year":"2014","unstructured":"O\u2019Reilly MW, House PJ, Tomlinson JW (2014) Understanding androgen action in adipose tissue. J Steroid Biochem Mol Biol 143:277\u2013284. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.04.008","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"3047_CR10","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1210\/jc.2018-02086","volume":"104","author":"DA Dumesic","year":"2019","unstructured":"Dumesic DA, Phan JD, Leung KL et al (2019) Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab 104(6):2171\u20132183. https:\/\/doi.org\/10.1210\/jc.2018-02086","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3047_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12958-021-00878-y","volume":"20","author":"DA Dumesic","year":"2022","unstructured":"Dumesic DA, Padmanabhan V, Chazenbalk GD, Abbott DH (2022) Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation. Reprod Biol Endocrinol 20(1):12. https:\/\/doi.org\/10.1186\/s12958-021-00878-y","journal-title":"Reprod Biol Endocrinol"},{"issue":"9","key":"3047_CR12","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1210\/jc.2017-00947","volume":"102","author":"MW O\u2019Reilly","year":"2017","unstructured":"O\u2019Reilly MW, Kempegowda P, Walsh M et al (2017) AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab 102(9):3327\u20133339. https:\/\/doi.org\/10.1210\/jc.2017-00947","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3047_CR13","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s12020-024-04077-8","volume":"87","author":"RB de Melo Cavalcante","year":"2025","unstructured":"de Melo Cavalcante RB, Le\u00e3o LMCSM, Tavares ABW et al (2025) Visceral adipose tissue, epicardial fat, and hepatic steatosis in polycystic ovary syndrome: a study of ectopic fat stores and metabolic dysfunction. Endocrine 87(2):866\u2013874. https:\/\/doi.org\/10.1007\/s12020-024-04077-8","journal-title":"Endocrine"},{"issue":"9","key":"3047_CR14","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","volume":"38","author":"A Dunaif","year":"1989","unstructured":"Dunaif A, Segal KR, Futterweit W, Dobrjansky A (1989) Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome. Diabetes 38(9):1165\u20131174. https:\/\/doi.org\/10.2337\/diab.38.9.1165","journal-title":"Diabetes"},{"issue":"6","key":"3047_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications. Endocr Rev 33(6):981\u20131030. https:\/\/doi.org\/10.1210\/er.2011-1034","journal-title":"Endocr Rev"},{"issue":"11","key":"3047_CR16","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1210\/jc.2016-2586","volume":"101","author":"DA Dumesic","year":"2016","unstructured":"Dumesic DA, Akopians AL, Madrigal VK et al (2016) Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women. J Clin Endocrinol Metab 101(11):4178\u20134188. https:\/\/doi.org\/10.1210\/jc.2016-2586","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3047_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.rbmo.2020.04.024","volume":"41","author":"SH Oguz","year":"2020","unstructured":"Oguz SH, \u0130dilman I, Helvaci N et al (2020) Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome. Reprod Biomed Online 41(2):329\u2013334. https:\/\/doi.org\/10.1016\/j.rbmo.2020.04.024","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"3047_CR18","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1210\/clinem\/dgaf272","volume":"111","author":"C Shan","year":"2025","unstructured":"Shan C, Yu J, Zhu YC et al (2025) Pancreatic Body and Hepatic Fat Content Predict Impaired Glucose Regulation in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab 111(1):e247\u2013e259. https:\/\/doi.org\/10.1210\/clinem\/dgaf272","journal-title":"J Clin Endocrinol Metab"},{"key":"3047_CR19","doi-asserted-by":"publisher","first-page":"108810","DOI":"10.1016\/j.maturitas.2025.108810","volume":"205","author":"S Aksun","year":"2026","unstructured":"Aksun S, \u00c7elik Ero\u011flu B, Gunesli I, Idilman I, Kar\u00e7aalt\u0131n\u00e7aba M, Yildiz BO (2026) Divergent fat deposition in PCOS: A preliminary comparative analysis of pancreatic and hepatic steatosis in aging clinical and unselected populations. Maturitas 205:108810. https:\/\/doi.org\/10.1016\/j.maturitas.2025.108810","journal-title":"Maturitas"},{"issue":"7","key":"3047_CR20","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1210\/jc.2006-2725","volume":"92","author":"E Carmina","year":"2007","unstructured":"Carmina E, Bucchieri S, Esposito A et al (2007) Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 92(7):2500\u20132505. https:\/\/doi.org\/10.1210\/jc.2006-2725","journal-title":"J Clin Endocrinol Metab"},{"issue":"36","key":"3047_CR21","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.2174\/1381612822666160715143933","volume":"22","author":"BO Saydam","year":"2016","unstructured":"Saydam BO, Yildiz BO (2016) Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome. Curr Pharm Des 22(36):5572\u20135587. https:\/\/doi.org\/10.2174\/1381612822666160715143933","journal-title":"Curr Pharm Des"},{"issue":"12","key":"3047_CR22","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41575-023-00830-y","volume":"20","author":"R Bany Bakar","year":"2023","unstructured":"Bany Bakar R, Reimann F, Gribble FM (2023) The intestine as an endocrine organ and the role of gut hormones in metabolic regulation. Nat Rev Gastroenterol Hepatol 20(12):784\u2013796. https:\/\/doi.org\/10.1038\/s41575-023-00830-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"3047_CR23","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.3390\/biomedicines12092129","volume":"12","author":"S Hemat Jouy","year":"2024","unstructured":"Hemat Jouy S, Mohan S, Scichilone G, Mostafa A, Mahmoud AM (2024) Adipokines in the Crosstalk between Adipose Tissues and Other Organs: Implications in Cardiometabolic Diseases. Biomedicines 12(9):2129. https:\/\/doi.org\/10.3390\/biomedicines12092129","journal-title":"Biomedicines"},{"issue":"2","key":"3047_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/1464727022000198952","volume":"5","author":"J Lord","year":"2002","unstructured":"Lord J, Wilkin T (2002) Polycystic ovary syndrome and fat distribution: The central issue? Hum Fertil 5(2):67\u201371. https:\/\/doi.org\/10.1080\/1464727022000198952","journal-title":"Hum Fertil"},{"issue":"6778","key":"3047_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/35007534","volume":"404","author":"MW Schwartz","year":"2000","unstructured":"Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404(6778):661\u2013671. https:\/\/doi.org\/10.1038\/35007534","journal-title":"Nature"},{"issue":"14","key":"3047_CR26","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.3390\/ijms22147737","volume":"22","author":"L Kerem","year":"2021","unstructured":"Kerem L, Lawson EA (2021) The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans. Int J Mol Sci 22(14):7737. https:\/\/doi.org\/10.3390\/ijms22147737","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3047_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5483\/bmbrep.2015.48.4.272","volume":"48","author":"JW Sohn","year":"2015","unstructured":"Sohn JW (2015) Network of hypothalamic neurons that control appetite. BMB Rep 48(4):229\u2013233. https:\/\/doi.org\/10.5483\/bmbrep.2015.48.4.272","journal-title":"BMB Rep"},{"issue":"2","key":"3047_CR28","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1210\/clinem\/dgaa843","volume":"106","author":"B Ozgen Saydam","year":"2021","unstructured":"Ozgen Saydam B, Yildiz BO (2021) Polycystic Ovary Syndrome and Brain: An Update on Structural and Functional Studies. J Clin Endocrinol Metab 106(2):e430\u2013e441. https:\/\/doi.org\/10.1210\/clinem\/dgaa843","journal-title":"J Clin Endocrinol Metab"},{"key":"3047_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2014.02.037","volume":"1558","author":"DA Van Vugt","year":"2014","unstructured":"Van Vugt DA, Krzemien A, Alsaadi H, Frank TC, Reid RL (2014) Glucose-induced inhibition of the appetitive brain response to visual food cues in polycystic ovary syndrome patients. Brain Res 1558:44\u201356. https:\/\/doi.org\/10.1016\/j.brainres.2014.02.037","journal-title":"Brain Res"},{"issue":"6","key":"3047_CR30","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/oby.20148","volume":"21","author":"DA Van Vugt","year":"2013","unstructured":"Van Vugt DA, Krzemien A, Alsaadi H, Palerme S, Reid RL (2013) Effect of insulin sensitivity on corticolimbic responses to food picture in women with polycystic ovary syndrome. Obes (Silver Spring) 21(6):1215\u20131222. https:\/\/doi.org\/10.1002\/oby.20148","journal-title":"Obes (Silver Spring)"},{"key":"3047_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.appet.2016.11.010","volume":"109","author":"YM Jeanes","year":"2017","unstructured":"Jeanes YM, Reeves S, Gibson EL, Piggott C, May VA, Hart KH (2017) Binge eating behaviours and food cravings in women with Polycystic Ovary Syndrome. Appetite 109:24\u201332. https:\/\/doi.org\/10.1016\/j.appet.2016.11.010","journal-title":"Appetite"},{"issue":"4","key":"3047_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber TM, Franks S (2021) Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 95(4):531\u2013541. https:\/\/doi.org\/10.1111\/cen.14421","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3047_CR33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.appet.2012.05.024","volume":"71","author":"A Sclafani","year":"2013","unstructured":"Sclafani A (2013) Gut-brain nutrient signaling. Appetition vs. satiation. Appetite 71:454\u2013458. https:\/\/doi.org\/10.1016\/j.appet.2012.05.024","journal-title":"Appetite"},{"issue":"2","key":"3047_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/dmrr.1154","volume":"27","author":"H Schloegl","year":"2011","unstructured":"Schloegl H, Percik R, Horstmann A, Villringer A, Stumvoll M (2011) Peptide hormones regulating appetite\u2013focus on neuroimaging studies in humans. Diabetes Metab Res Rev 27(2):104\u2013112. https:\/\/doi.org\/10.1002\/dmrr.1154","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"3047_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1210\/endrev\/bnz012","volume":"41","author":"SE McCormack","year":"2020","unstructured":"McCormack SE, Blevins JE, Lawson EA (2020) Metabolic Effects of Oxytocin. Endocr Rev 41(2):121\u2013145. https:\/\/doi.org\/10.1210\/endrev\/bnz012","journal-title":"Endocr Rev"},{"issue":"5","key":"3047_CR36","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/oby.21069","volume":"23","author":"EA Lawson","year":"2015","unstructured":"Lawson EA, Marengi DA, DeSanti RL, Holmes TM, Schoenfeld DA, Tolley CJ (2015) Oxytocin reduces caloric intake in men. Obesity 23(5):950\u2013956. https:\/\/doi.org\/10.1002\/oby.21069","journal-title":"Obesity"},{"issue":"12","key":"3047_CR37","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrendo.2017.115","volume":"13","author":"EA Lawson","year":"2017","unstructured":"Lawson EA (2017) The effects of oxytocin on eating behaviour and metabolism in humans. Nat Rev Endocrinol 13(12):700\u2013709. https:\/\/doi.org\/10.1038\/nrendo.2017.115","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"3047_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/obr.12757","volume":"20","author":"C Ding","year":"2019","unstructured":"Ding C, Leow MKS, Magkos F (2019) Oxytocin in metabolic homeostasis: implications for obesity and diabetes management. Obes Rev 20(1):22\u201340. https:\/\/doi.org\/10.1111\/obr.12757","journal-title":"Obes Rev"},{"issue":"5","key":"3047_CR39","doi-asserted-by":"publisher","first-page":"EVIDoa2300349","DOI":"10.1056\/EVIDoa2300349","volume":"3","author":"F Plessow","year":"2024","unstructured":"Plessow F, Kerem L, Wronski ML et al (2024) Intranasal Oxytocin for Obesity. NEJM Evid 3(5):EVIDoa2300349. https:\/\/doi.org\/10.1056\/EVIDoa2300349","journal-title":"NEJM Evid"},{"issue":"12","key":"3047_CR40","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.18632\/aging.100408","volume":"3","author":"Y Maejima","year":"2011","unstructured":"Maejima Y, Iwasaki Y, Yamahara Y, Kodaira M, Sedbazar U, Yada T (2011) Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging 3(12):1169\u20131177. https:\/\/doi.org\/10.18632\/aging.100408","journal-title":"Aging"},{"issue":"4","key":"3047_CR41","doi-asserted-by":"publisher","first-page":"R471","DOI":"10.1152\/ajpregu.00294.2020","volume":"320","author":"MM Edwards","year":"2021","unstructured":"Edwards MM, Nguyen HK, Herbertson AJ et al (2021) Chronic hindbrain administration of oxytocin elicits weight loss in male diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 320(4):R471\u2013R487. https:\/\/doi.org\/10.1152\/ajpregu.00294.2020","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"3047_CR42","doi-asserted-by":"publisher","first-page":"114534","DOI":"10.1016\/j.yexcr.2025.114534","volume":"447","author":"X Bao","year":"2025","unstructured":"Bao X, San M, Wang S et al (2025) Oxytocin receptor enhances adipocyte browning and energy metabolism in mice. Exp Cell Res 447(2):114534. https:\/\/doi.org\/10.1016\/j.yexcr.2025.114534","journal-title":"Exp Cell Res"},{"issue":"7993","key":"3047_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41586-023-06830-x","volume":"625","author":"E Li","year":"2024","unstructured":"Li E, Wang L, Wang D et al (2024) Control of lipolysis by a population of oxytocinergic sympathetic neurons. Nature 625(7993):175\u2013180. https:\/\/doi.org\/10.1038\/s41586-023-06830-x","journal-title":"Nature"},{"issue":"9","key":"3047_CR44","doi-asserted-by":"publisher","first-page":"e25565","DOI":"10.1371\/journal.pone.0025565","volume":"6","author":"N Deblon","year":"2011","unstructured":"Deblon N, Veyrat-Durebex C, Bourgoin L et al (2011) Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS ONE 6(9):e25565. https:\/\/doi.org\/10.1371\/journal.pone.0025565","journal-title":"PLoS ONE"},{"issue":"4","key":"3047_CR45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tjog.2018.06.015","volume":"57","author":"BN Jahromi","year":"2018","unstructured":"Jahromi BN, Dabbaghmanesh MH, Bakhshaie P et al (2018) Assessment of oxytocin level, glucose metabolism components and cutoff values for oxytocin and anti-mullerian hormone in infertile PCOS women. Taiwan J Obstet Gynecol 57(4):555\u2013559. https:\/\/doi.org\/10.1016\/j.tjog.2018.06.015","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"3047_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/ejendo\/lvaf154","volume":"193","author":"I Gunesli","year":"2025","unstructured":"Gunesli I, Ulug E, Pinar AA, Portakal O, Yildiz BO (2025) Fasting and postprandial oxytocin and incretin dynamics in women with polycystic ovary syndrome and healthy controls. Eur J Endocrinol 193(2):255\u2013261. https:\/\/doi.org\/10.1093\/ejendo\/lvaf154","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"3047_CR47","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.26355\/eurrev_202303_31800","volume":"27","author":"M Amin","year":"2023","unstructured":"Amin M, Horst N, Wu R, Gragnoli C (2023) Oxytocin receptor (OXTR) is a risk gene for polycystic ovarian syndrome. Eur Rev Med Pharmacol Sci 27(6):2634\u20132639. https:\/\/doi.org\/10.26355\/eurrev_202303_31800","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3047_CR48","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1111\/j.1749-6632.2012.06491.x","volume":"1243","author":"LK Phillips","year":"2011","unstructured":"Phillips LK, Prins JB (2011) Update on incretin hormones. Ann N Y Acad Sci 1243:E55\u201374. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06491.x","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"3047_CR49","doi-asserted-by":"publisher","first-page":"e0119034","DOI":"10.1371\/journal.pone.0119034","volume":"10","author":"JE Richard","year":"2015","unstructured":"Richard JE, Anderberg RH, G\u00f6teson A, Gribble FM, Reimann F, Skibicka KP (2015) Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System. PLoS ONE 10(3):e0119034. https:\/\/doi.org\/10.1371\/journal.pone.0119034","journal-title":"PLoS ONE"},{"issue":"3","key":"3047_CR50","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4093\/dmj.2023.0277","volume":"48","author":"T Bu","year":"2024","unstructured":"Bu T, Sun Z, Pan Y, Deng X, Yuan G (2024) Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism. Diabetes Metab J 48(3):354\u2013372. https:\/\/doi.org\/10.4093\/dmj.2023.0277","journal-title":"Diabetes Metab J"},{"key":"3047_CR51","doi-asserted-by":"publisher","unstructured":"Gallwitz B (2012) Anorexigenic Effects of GLP-1 and Its Analogues. 185\u2013207. https:\/\/doi.org\/10.1007\/978-3-642-24716-3_8","DOI":"10.1007\/978-3-642-24716-3_8"},{"key":"3047_CR52","doi-asserted-by":"publisher","unstructured":"Petit JM, Verg\u00e8s B (2017) GLP-1 receptor agonists in NAFLD. Diabetes Metab 43(Suppl 1). https:\/\/doi.org\/10.1016\/S1262-3636(17)30070-8. :2S28-2S33","DOI":"10.1016\/S1262-3636(17)30070-8"},{"issue":"8","key":"3047_CR53","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1111\/dom.15113","volume":"25","author":"HJ Silver","year":"2023","unstructured":"Silver HJ, Olson D, Mayfield D et al (2023) Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes. Diabetes Obes Metab 25(8):2340\u20132350. https:\/\/doi.org\/10.1111\/dom.15113","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"3047_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/dom.13053","volume":"20","author":"S Fr\u00f8ssing","year":"2018","unstructured":"Fr\u00f8ssing S, Nylander M, Chabanova E et al (2018) Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial. Diabetes Obes Metab 20(1):215\u2013218. https:\/\/doi.org\/10.1111\/dom.13053","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"3047_CR55","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1111\/bph.13481","volume":"173","author":"R El Bekay","year":"2016","unstructured":"El Bekay R, Co\u00edn-Arag\u00fcez L, Fern\u00e1ndez-Garc\u00eda D et al (2016) Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes. Br J Pharmacol 173(11):1820\u20131834. https:\/\/doi.org\/10.1111\/bph.13481","journal-title":"Br J Pharmacol"},{"issue":"4","key":"3047_CR56","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/cen.12468","volume":"81","author":"K Aydin","year":"2014","unstructured":"Aydin K, Arusoglu G, Koksal G, Cinar N, Yazgan Aksoy D, Yildiz BO (2014) Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome. Clin Endocrinol (Oxf) 81(4):588\u2013592. https:\/\/doi.org\/10.1111\/cen.12468","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"3047_CR57","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","volume":"105","author":"H Cena","year":"2020","unstructured":"Cena H, Chiovato L, Nappi RE, Obesity (2020) Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab 105(8):e2695\u2013e2709. https:\/\/doi.org\/10.1210\/clinem\/dgaa285","journal-title":"J Clin Endocrinol Metab"},{"key":"3047_CR58","doi-asserted-by":"publisher","unstructured":"Jensterle M, Herman R, Jane\u017e A (2022) Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives. Biomedicines 10(8). https:\/\/doi.org\/10.3390\/biomedicines10081989","DOI":"10.3390\/biomedicines10081989"},{"issue":"7121","key":"3047_CR59","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nature05484","volume":"444","author":"KG Murphy","year":"2006","unstructured":"Murphy KG, Bloom SR (2006) Gut hormones and the regulation of energy homeostasis. Nature 444(7121):854\u2013859. https:\/\/doi.org\/10.1038\/nature05484","journal-title":"Nature"},{"issue":"9","key":"3047_CR60","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.2337\/db10-0098","volume":"59","author":"M Asmar","year":"2010","unstructured":"Asmar M, Simonsen L, Madsbad S, Stallknecht B, Holst JJ, B\u00fclow J (2010) Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans. Diabetes 59(9):2160\u20132163. https:\/\/doi.org\/10.2337\/db10-0098","journal-title":"Diabetes"},{"issue":"2","key":"3047_CR61","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1530\/EJE-08-0097","volume":"159","author":"J Vrbikova","year":"2008","unstructured":"Vrbikova J, Hill M, Bendlova B et al (2008) Incretin levels in polycystic ovary syndrome. Eur J Endocrinol 159(2):121\u2013127. https:\/\/doi.org\/10.1530\/EJE-08-0097","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"3047_CR62","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrendo.2014.91","volume":"10","author":"S Murray","year":"2014","unstructured":"Murray S, Tulloch A, Gold MS, Avena NM (2014) Hormonal and neural mechanisms of food reward, eating behaviour and obesity. Nat Rev Endocrinol 10(9):540\u2013552. https:\/\/doi.org\/10.1038\/nrendo.2014.91","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"3047_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1172\/JCI114425","volume":"85","author":"P Valet","year":"1990","unstructured":"Valet P, Berlan M, Beauville M, Crampes F, Montastruc JL, Lafontan M (1990) Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein. J Clin Invest 85(1):291\u2013295. https:\/\/doi.org\/10.1172\/JCI114425","journal-title":"J Clin Invest"},{"issue":"5","key":"3047_CR64","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/ijo.2009.40","volume":"33","author":"A Rodr\u00edguez","year":"2009","unstructured":"Rodr\u00edguez A, G\u00f3mez-Ambrosi J, Catal\u00e1n V et al (2009) Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes 33(5):541\u2013552. https:\/\/doi.org\/10.1038\/ijo.2009.40","journal-title":"Int J Obes"},{"issue":"4","key":"3047_CR65","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.physbeh.2004.07.031","volume":"83","author":"C Beglinger","year":"2004","unstructured":"Beglinger C, Degen L (2004) Fat in the intestine as a regulator of appetite\u2013role of CCK. Physiol Behav 83(4):617\u2013621. https:\/\/doi.org\/10.1016\/j.physbeh.2004.07.031","journal-title":"Physiol Behav"},{"issue":"5","key":"3047_CR66","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jpag.2010.02.011","volume":"23","author":"IT Ozgen","year":"2010","unstructured":"Ozgen IT, Aydin M, Guven A, Aliyazic\u0131oglu Y (2010) Characteristics of polycystic ovarian syndrome and relationship with ghrelin in adolescents. J Pediatr Adolesc Gynecol 23(5):285\u2013289. https:\/\/doi.org\/10.1016\/j.jpag.2010.02.011","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"Suppl 2","key":"3047_CR67","first-page":"161","volume":"59","author":"K Zwirska-Korczala","year":"2008","unstructured":"Zwirska-Korczala K, Sodowski K, Konturek SJ et al (2008) Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome. J Physiol Pharmacol 59(Suppl 2):161\u2013178","journal-title":"J Physiol Pharmacol"},{"issue":"11","key":"3047_CR68","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1210\/jc.2013-1526","volume":"98","author":"G Arusoglu","year":"2013","unstructured":"Arusoglu G, Koksal G, Cinar N, Tapan S, Aksoy DY, Yildiz BO (2013) Basal and Meal-Stimulated Ghrelin, PYY, CCK Levels and Satiety in Lean Women With Polycystic Ovary Syndrome: Effect of Low-Dose Oral Contraceptive. J Clin Endocrinol Metab 98(11):4475\u20134482. https:\/\/doi.org\/10.1210\/jc.2013-1526","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3047_CR69","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1210\/jc.2002-021451","volume":"88","author":"F Orio","year":"2003","unstructured":"Orio F, Lucidi P, Palomba S et al (2003) Circulating ghrelin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 88(2):942\u2013945. https:\/\/doi.org\/10.1210\/jc.2002-021451","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3047_CR70","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1093\/ajcn\/86.5.1603","volume":"86","author":"LJ Moran","year":"2007","unstructured":"Moran LJ, Noakes M, Clifton PM et al (2007) Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. Am J Clin Nutr 86(6):1603\u20131610. https:\/\/doi.org\/10.1093\/ajcn\/86.5.1603","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"3047_CR71","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","volume":"23","author":"JH Stern","year":"2016","unstructured":"Stern JH, Rutkowski JM, Scherer PE (2016) Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. Cell Metab 23(5):770\u2013784. https:\/\/doi.org\/10.1016\/j.cmet.2016.04.011","journal-title":"Cell Metab"},{"issue":"2","key":"3047_CR72","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1530\/eje.1.02207","volume":"155","author":"D Glintborg","year":"2006","unstructured":"Glintborg D, Andersen M, Hagen C et al (2006) Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 155(2):337\u2013345. https:\/\/doi.org\/10.1530\/eje.1.02207","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"3047_CR73","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/humupd\/dmp006","volume":"15","author":"KA Toulis","year":"2009","unstructured":"Toulis KA, Goulis DG, Farmakiotis D et al (2009) Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 15(3):297\u2013307. https:\/\/doi.org\/10.1093\/humupd\/dmp006","journal-title":"Hum Reprod Update"},{"key":"3047_CR74","doi-asserted-by":"publisher","unstructured":"Lin K, Sun X, Wang X, Wang H, Chen X (2021) Circulating Adipokine Levels in Nonobese Women With Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 11. https:\/\/doi.org\/10.3389\/fendo.2020.537809","DOI":"10.3389\/fendo.2020.537809"},{"key":"3047_CR75","doi-asserted-by":"publisher","first-page":"8225","DOI":"10.2147\/IJGM.S384073","volume":"15","author":"MAA Osman","year":"2022","unstructured":"Osman MAA, Alkhouly M, Elmohaseb GF et al (2022) Relation Between Non-Alcoholic Fatty Pancreas and Clinical and Biochemical Parameters in Women with Polycystic Ovary Syndrome: A Multi-Centric Study. Int J Gen Med 15:8225\u20138233. https:\/\/doi.org\/10.2147\/IJGM.S384073","journal-title":"Int J Gen Med"},{"key":"3047_CR76","doi-asserted-by":"publisher","first-page":"697223","DOI":"10.3389\/fendo.2021.697223","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu S, Li Z, Hu C et al (2021) Imaging-Based Body Fat Distribution in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 12:697223. https:\/\/doi.org\/10.3389\/fendo.2021.697223","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"3047_CR77","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/0026-0495(94)90118-x","volume":"43","author":"R Pasquali","year":"1994","unstructured":"Pasquali R, Casimirri F, Venturoli S et al (1994) Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome. Metabolism 43(6):706\u2013713. https:\/\/doi.org\/10.1016\/0026-0495(94)90118-x","journal-title":"Metabolism"},{"issue":"6","key":"3047_CR78","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2337\/db06-0263","volume":"55","author":"PE Scherer","year":"2006","unstructured":"Scherer PE (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55(6):1537\u20131545. https:\/\/doi.org\/10.2337\/db06-0263","journal-title":"Diabetes"},{"issue":"10","key":"3047_CR79","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1007\/s00125-012-2639-5","volume":"55","author":"BM Kaess","year":"2012","unstructured":"Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS (2012) The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia 55(10):2622\u20132630. https:\/\/doi.org\/10.1007\/s00125-012-2639-5","journal-title":"Diabetologia"},{"key":"3047_CR80","doi-asserted-by":"publisher","unstructured":"Janssen JAMJL (2024) The Causal Role of Ectopic Fat Deposition in the Pathogenesis of Metabolic Syndrome. Int J Mol Sci 25(24). https:\/\/doi.org\/10.3390\/ijms252413238","DOI":"10.3390\/ijms252413238"},{"issue":"7","key":"3047_CR81","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","volume":"87","author":"A Sepp\u00e4l\u00e4-Lindroos","year":"2002","unstructured":"Sepp\u00e4l\u00e4-Lindroos A, Vehkavaara S, H\u00e4kkinen AM et al (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87(7):3023\u20133028. https:\/\/doi.org\/10.1210\/jcem.87.7.8638","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3047_CR82","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1210\/jc.2010-2190","volume":"96","author":"KC Sung","year":"2011","unstructured":"Sung KC, Kim SH (2011) Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J Clin Endocrinol Metab 96(4):1093\u20131097. https:\/\/doi.org\/10.1210\/jc.2010-2190","journal-title":"J Clin Endocrinol Metab"},{"key":"3047_CR83","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13048-015-0197-4","volume":"8","author":"D Arpaci","year":"2015","unstructured":"Arpaci D, Gurkan Tocoglu A, Yilmaz S et al (2015) The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome. J Ovarian Res 8:71. https:\/\/doi.org\/10.1186\/s13048-015-0197-4","journal-title":"J Ovarian Res"},{"issue":"6","key":"3047_CR84","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1507\/endocrj.ej11-0328","volume":"59","author":"A Aydogdu","year":"2012","unstructured":"Aydogdu A, Uckaya G, Tasci I et al (2012) The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome. Endocr J 59(6):509\u2013516. https:\/\/doi.org\/10.1507\/endocrj.ej11-0328","journal-title":"Endocr J"},{"issue":"1","key":"3047_CR85","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/humrep\/dem356","volume":"23","author":"T Cascella","year":"2008","unstructured":"Cascella T, Palomba S, De Sio I et al (2008) Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod 23(1):153\u2013159. https:\/\/doi.org\/10.1093\/humrep\/dem356","journal-title":"Hum Reprod"},{"issue":"5","key":"3047_CR86","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.fertnstert.2022.03.020","volume":"117","author":"I Doycheva","year":"2022","unstructured":"Doycheva I, Ehrmann DA (2022) Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome. Fertil Steril 117(5):897\u2013911. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.03.020","journal-title":"Fertil Steril"},{"issue":"2","key":"3047_CR87","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12020-015-0640-8","volume":"51","author":"G Targher","year":"2016","unstructured":"Targher G, Rossini M, Lonardo A (2016) Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis? Endocrine 51(2):211\u2013221. https:\/\/doi.org\/10.1007\/s12020-015-0640-8","journal-title":"Endocrine"},{"key":"3047_CR88","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","volume":"50","author":"K Pafili","year":"2021","unstructured":"Pafili K, Roden M (2021) Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Mol Metab 50:101122. https:\/\/doi.org\/10.1016\/j.molmet.2020.101122","journal-title":"Mol Metab"},{"issue":"1","key":"3047_CR89","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1):328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"issue":"38","key":"3047_CR90","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.2174\/1381612825666190117100751","volume":"24","author":"D Macut","year":"2018","unstructured":"Macut D, Bjeki\u0107-Macut J, Livadas S et al (2018) Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome. Curr Pharm Des 24(38):4593\u20134597. https:\/\/doi.org\/10.2174\/1381612825666190117100751","journal-title":"Curr Pharm Des"},{"issue":"2","key":"3047_CR91","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51(2):679\u2013689. https:\/\/doi.org\/10.1002\/hep.23280","journal-title":"Hepatology"},{"issue":"11","key":"3047_CR92","doi-asserted-by":"publisher","first-page":"e0186136","DOI":"10.1371\/journal.pone.0186136","volume":"12","author":"S Petta","year":"2017","unstructured":"Petta S, Ciresi A, Bianco J et al (2017) Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS. PLoS ONE 12(11):e0186136. https:\/\/doi.org\/10.1371\/journal.pone.0186136","journal-title":"PLoS ONE"},{"issue":"11","key":"3047_CR93","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2337\/dc12-0701","volume":"35","author":"LS Szczepaniak","year":"2012","unstructured":"Szczepaniak LS, Victor RG, Mathur R et al (2012) Pancreatic Steatosis and Its Relationship to \u03b2-Cell Dysfunction in Humans. Diabetes Care 35(11):2377\u20132383. https:\/\/doi.org\/10.2337\/dc12-0701","journal-title":"Diabetes Care"},{"issue":"3","key":"3047_CR94","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/dmrr.1073","volume":"26","author":"M Heni","year":"2010","unstructured":"Heni M, Machann J, Staiger H et al (2010) Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and\/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 26(3):200\u2013205. https:\/\/doi.org\/10.1002\/dmrr.1073","journal-title":"Diabetes Metab Res Rev"},{"issue":"10","key":"3047_CR95","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1210\/jc.2012-1382","volume":"97","author":"H Jones","year":"2012","unstructured":"Jones H, Sprung VS, Pugh CJA et al (2012) Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. J Clin Endocrinol Metab 97(10):3709\u20133716. https:\/\/doi.org\/10.1210\/jc.2012-1382","journal-title":"J Clin Endocrinol Metab"},{"key":"3047_CR96","doi-asserted-by":"publisher","first-page":"1053709","DOI":"10.3389\/fendo.2022.1053709","volume":"13","author":"MJ Song","year":"2022","unstructured":"Song MJ, Choi JY (2022) Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin. Front Endocrinol (Lausanne) 13:1053709. https:\/\/doi.org\/10.3389\/fendo.2022.1053709","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"3047_CR97","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1172\/JCI32249","volume":"117","author":"DM Selva","year":"2007","unstructured":"Selva DM, Hogeveen KN, Innis SM, Hammond GL (2007) Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest 117(12):3979\u20133987. https:\/\/doi.org\/10.1172\/JCI32249","journal-title":"J Clin Invest"},{"key":"3047_CR98","doi-asserted-by":"publisher","first-page":"107922","DOI":"10.1016\/j.psyneuen.2026.107922","volume":"191","author":"BO Yildiz","year":"2026","unstructured":"Yildiz BO (2026) From PCOS to PMOS: Beyond ovarian morphology to neuroendocrine networks. Psychoneuroendocrinology 191:107922. https:\/\/doi.org\/10.1016\/j.psyneuen.2026.107922","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"3047_CR99","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13048-025-01724-0","volume":"18","author":"S Zhang","year":"2025","unstructured":"Zhang S, Jiang N, Liu G et al (2025) New perspectives on polycystic ovary syndrome: hypothalamic-sympathetic-adipose tissue interaction. J Ovarian Res 18(1):145. https:\/\/doi.org\/10.1186\/s13048-025-01724-0","journal-title":"J Ovarian Res"},{"issue":"1","key":"3047_CR100","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/oby.2008.491","volume":"17","author":"M Luque-Ram\u00edrez","year":"2009","unstructured":"Luque-Ram\u00edrez M, Alvarez-Blasco F, Escobar-Morreale HF (2009) Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients. Obes (Silver Spring) 17(1):3\u20139. https:\/\/doi.org\/10.1038\/oby.2008.491","journal-title":"Obes (Silver Spring)"},{"key":"3047_CR101","doi-asserted-by":"publisher","first-page":"101175","DOI":"10.1016\/j.molmet.2021.101175","volume":"46","author":"P Richards","year":"2021","unstructured":"Richards P, Thornberry NA, Pinto S (2021) The gut\u2013brain axis: Identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders. Mol Metab 46:101175. https:\/\/doi.org\/10.1016\/j.molmet.2021.101175","journal-title":"Mol Metab"},{"issue":"12","key":"3047_CR102","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1038\/s44319-024-00321-4","volume":"25","author":"F D\u00edaz-Castro","year":"2024","unstructured":"D\u00edaz-Castro F, Morselli E, Claret M (2024) Interplay between the brain and adipose tissue: a metabolic conversation. EMBO Rep 25(12):5277\u20135293. https:\/\/doi.org\/10.1038\/s44319-024-00321-4","journal-title":"EMBO Rep"},{"issue":"7","key":"3047_CR103","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/09513590.2017.1295440","volume":"33","author":"B Ozgen Saydam","year":"2017","unstructured":"Ozgen Saydam B, Has AC, Bozdag G, Oguz KK, Yildiz BO (2017) Structural imaging of the brain reveals decreased total brain and total gray matter volumes in obese but not in lean women with polycystic ovary syndrome compared to body mass index-matched counterparts. Gynecol Endocrinol 33(7):519\u2013523. https:\/\/doi.org\/10.1080\/09513590.2017.1295440","journal-title":"Gynecol Endocrinol"},{"key":"3047_CR104","doi-asserted-by":"publisher","first-page":"667422","DOI":"10.3389\/fendo.2021.667422","volume":"12","author":"B Liao","year":"2021","unstructured":"Liao B, Qiao J, Pang Y (2021) Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology. Front Endocrinol (Lausanne) 12:667422. https:\/\/doi.org\/10.3389\/fendo.2021.667422","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"3047_CR105","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.18632\/aging.206244","volume":"17","author":"K Hattori","year":"2025","unstructured":"Hattori K, Shimizu M, Yamachi M et al (2025) Oxytocin modulates insulin and GLP-1 secretion in pancreatic islets. Aging 17(5):1139\u20131147. https:\/\/doi.org\/10.18632\/aging.206244","journal-title":"Aging"},{"issue":"1","key":"3047_CR106","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1152\/ajpregu.00008.2002","volume":"283","author":"L Rinaman","year":"2002","unstructured":"Rinaman L, Rothe EE (2002) GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats. Am J Physiology-Regulatory Integr Comp Physiol 283(1):R99\u2013R106. https:\/\/doi.org\/10.1152\/ajpregu.00008.2002","journal-title":"Am J Physiology-Regulatory Integr Comp Physiol"},{"issue":"19","key":"3047_CR107","doi-asserted-by":"publisher","first-page":"10859","DOI":"10.3390\/ijms221910859","volume":"22","author":"CM Liu","year":"2021","unstructured":"Liu CM, Spaulding MO, Rea JJ, Noble EE, Kanoski SE (2021) Oxytocin and Food Intake Control: Neural, Behavioral, and Signaling Mechanisms. Int J Mol Sci 22(19):10859. https:\/\/doi.org\/10.3390\/ijms221910859","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3047_CR108","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.bbrc.2014.07.116","volume":"451","author":"K Katsurada","year":"2014","unstructured":"Katsurada K, Maejima Y, Nakata M et al (2014) Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: Projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons. Biochem Biophys Res Commun 451(2):276\u2013281. https:\/\/doi.org\/10.1016\/j.bbrc.2014.07.116","journal-title":"Biochem Biophys Res Commun"},{"key":"3047_CR109","doi-asserted-by":"publisher","unstructured":"Goldberg A, Graca S, Liu J et al (2024) Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta\u2010analysis to inform the 2023 international evidence\u2010based guideline. Obes Rev 25(5). https:\/\/doi.org\/10.1111\/obr.13704","DOI":"10.1111\/obr.13704"},{"issue":"11","key":"3047_CR110","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41574-025-01174-0","volume":"21","author":"BO Yildiz","year":"2025","unstructured":"Yildiz BO (2025) PCOS research from the past to the future. Nat Rev Endocrinol 21(11):668\u2013670. https:\/\/doi.org\/10.1038\/s41574-025-01174-0","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"3047_CR111","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE et al (2023) Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab 108(10):2447\u20132469. https:\/\/doi.org\/10.1210\/clinem\/dgad463","journal-title":"J Clin Endocrinol Metab"},{"key":"3047_CR112","doi-asserted-by":"publisher","unstructured":"Szczesnowicz A, Szeliga A, Niwczyk O, Bala G, Meczekalski B, Do (2023) GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies. J Clin Med 12(18). https:\/\/doi.org\/10.3390\/jcm12185915","DOI":"10.3390\/jcm12185915"},{"issue":"1","key":"3047_CR113","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000547055","volume":"19","author":"O Celik","year":"2025","unstructured":"Celik O, Yazici D, Ciudin A et al (2025) GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity. Obes Facts 19(1):93\u2013108. https:\/\/doi.org\/10.1159\/000547055","journal-title":"Obes Facts"},{"key":"3047_CR114","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fendo.2014.00140","volume":"5","author":"CB Rasmussen","year":"2014","unstructured":"Rasmussen CB, Lindenberg S (2014) The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study. Front Endocrinol (Lausanne) 5:140. https:\/\/doi.org\/10.3389\/fendo.2014.00140","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3047_CR115","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.fertnstert.2022.04.027","volume":"118","author":"KE Elkind-Hirsch","year":"2022","unstructured":"Elkind-Hirsch KE, Chappell N, Shaler D, Storment J, Bellanger D (2022) Liraglutide 3\u00a0mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study. Fertil Steril 118(2):371\u2013381. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.04.027","journal-title":"Fertil Steril"},{"issue":"1","key":"3047_CR116","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s13679-025-00614-2","volume":"14","author":"M Diakosavvas","year":"2025","unstructured":"Diakosavvas M, Oyebode O, Bhide P (2025) Weight Management Strategies to Reduce Metabolic Morbidity in Women With Polycystic Ovary Syndrome. Curr Obes Rep 14(1):22. https:\/\/doi.org\/10.1007\/s13679-025-00614-2","journal-title":"Curr Obes Rep"},{"key":"3047_CR117","doi-asserted-by":"publisher","unstructured":"Carmina E, Longo RA (2023) Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs. J Clin Med 12(18). https:\/\/doi.org\/10.3390\/jcm12185921","DOI":"10.3390\/jcm12185921"},{"key":"3047_CR118","doi-asserted-by":"publisher","unstructured":"Yang Z, Xu Y, Du H et al (2026) Short-Term Combined Treatment With Tirzepatide and Metformin for Overweight\/Obese Chinese Women With Polycystic Ovary Syndrome: A Prospective, Open-Label, Randomised Controlled Trial. Diabetes Obes Metab Published online June 3. https:\/\/doi.org\/10.1111\/dom.70966","DOI":"10.1111\/dom.70966"},{"issue":"14","key":"3047_CR119","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.3390\/jcm12144575","volume":"12","author":"AD Anala","year":"2023","unstructured":"Anala AD, Saifudeen ISH, Ibrahim M, Nanda M, Naaz N, Atkin SL (2023) The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome. J Clin Med 12(14):4575. https:\/\/doi.org\/10.3390\/jcm12144575","journal-title":"J Clin Med"},{"issue":"1","key":"3047_CR120","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/09513590.2019.1631276","volume":"36","author":"T Iwasa","year":"2020","unstructured":"Iwasa T, Matsuzaki T, Mayila Y, Kawakita T, Yanagihara R, Irahara M (2020) The effects of chronic oxytocin administration on body weight and food intake in DHT-induced PCOS model rats. Gynecol Endocrinol 36(1):55\u201360. https:\/\/doi.org\/10.1080\/09513590.2019.1631276","journal-title":"Gynecol Endocrinol"},{"issue":"15","key":"3047_CR121","doi-asserted-by":"publisher","first-page":"8207","DOI":"10.3390\/ijms23158207","volume":"23","author":"S Yamamoto","year":"2022","unstructured":"Yamamoto S, Noguchi H, Takeda A et al (2022) Changes in Endogenous Oxytocin Levels and the Effects of Exogenous Oxytocin Administration on Body Weight Changes and Food Intake in Polycystic Ovary Syndrome Model Rats. Int J Mol Sci 23(15):8207. https:\/\/doi.org\/10.3390\/ijms23158207","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3047_CR122","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1476-5381.2010.01037.x","volume":"162","author":"M Eckertova","year":"2011","unstructured":"Eckertova M, Ondrejcakova M, Krskova K, Zorad S, Jezova D (2011) Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesis. Br J Pharmacol 162(2):452\u2013463. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01037.x","journal-title":"Br J Pharmacol"},{"key":"3047_CR123","doi-asserted-by":"publisher","unstructured":"Leng G, Sabatier N (2016) Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers. J Neuroendocrinol 28(10). https:\/\/doi.org\/10.1111\/jne.12413","DOI":"10.1111\/jne.12413"},{"issue":"1","key":"3047_CR124","doi-asserted-by":"publisher","first-page":"17222","DOI":"10.1038\/s41598-017-17674-7","volume":"7","author":"A Lefevre","year":"2017","unstructured":"Lefevre A, Mottolese R, Dirheimer M, Mottolese C, Duhamel JR, Sirigu A (2017) A comparison of methods to measure central and peripheral oxytocin concentrations in human and non-human primates. Sci Rep 7(1):17222. https:\/\/doi.org\/10.1038\/s41598-017-17674-7","journal-title":"Sci Rep"},{"issue":"8","key":"3047_CR125","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.neubiorev.2013.04.018","volume":"37","author":"ME McCullough","year":"2013","unstructured":"McCullough ME, Churchland PS, Mendez AJ (2013) Problems with measuring peripheral oxytocin: Can the data on oxytocin and human behavior be trusted? Neurosci Biobehav Rev 37(8):1485\u20131492. https:\/\/doi.org\/10.1016\/j.neubiorev.2013.04.018","journal-title":"Neurosci Biobehav Rev"},{"key":"3047_CR126","doi-asserted-by":"publisher","unstructured":"Olszewski PK, Noble EE, Paiva L, Ueta Y, Blevins JE (2022) Oxytocin as a potential pharmacological tool to combat obesity. J Neuroendocrinol 34(9). https:\/\/doi.org\/10.1111\/jne.13106","DOI":"10.1111\/jne.13106"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03047-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-03047-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03047-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:30Z","timestamp":1791576150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-03047-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":126,"alternative-id":["3047"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-03047-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"28 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors confirm that this article content has no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This review article does not report any original research involving human participants or animals, and therefore ethical approval and informed consent were not required.","order":2,"name":"Ethics","label":"Ethical approval and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}